A quality improvement project to reduce length of stay for neonatal abstinence syndrome

Pediatrics

Volumn 135, Issue 6, 2015, Pages e1494-e1500

  Asti, Lindsey ^a,b   Magers, Jacqueline S ^c   Keels, Erin ^c   Wispe, Jonathan ^c,d   McClead, Richard E ^c,e  

^a Research Institute   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG TREATMENT FAILURE; EDUCATION PROGRAM; ENTERAL DRUG ADMINISTRATION; FEMALE; FINNEGAN SCORING; HEALTH CARE QUALITY; HOSPITAL READMISSION; HUMAN; INFANT; INTERDISCIPLINARY COMMUNICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PRIORITY JOURNAL; SCORING SYSTEM; TOTAL QUALITY MANAGEMENT; WITHDRAWAL SYNDROME; NEONATAL ABSTINENCE SYNDROME; NEWBORN; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; NEONATAL ABSTINENCE SYNDROME; QUALITY IMPROVEMENT;

EID: 84930586870     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1269     Document Type: Article

References (22)

1. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. In: Department of Health and Human Services, ed. Summary of National Findings (Office of Applied Studies, NSDUH Series H-46, HHS Publication No SMA 13-4795). Rockville, MD: Center for Behavioral Health Statistics and Quality; 2013
2. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care. 2005;5(5):265-272
3. Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012;129(2). Available at: www.pediatrics.org/cgi/content/full/129/2/e540
4. Theis JG, Selby P, Ikizler Y, Koren G. Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. Biol Neonate. 1997;71(6):345-356
5. Grim K, Harrison TE, Wilder RT. Management of neonatal abstinence syndrome from opioids. Clin Perinatol. 2013;40(3):509-524
6. Narkowicz S, Płotka J, Polkowska Ż, Biziuk M, Namieśnik J. Prenatal exposure to substance of abuse: a worldwide problem. Environ Int. 2013;54:141-163
7. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006;26(1):15-17
8. Kraft WK, Gibson E, Dysart K, et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics. 2008;122(3). Available at: www.pediatrics.org/cgi/content/full/122/3/e601
9. Johnson K, Greenough A, Gerada C. Maternal drug use and length of neonatal unit stay. Addiction. 2003;98(6):785-789
10. Napolitano A, Theophilopoulos D, Seng SK, Calhoun DA. Pharmacologic management of neonatal abstinence syndrome in a community hospital. Clin Obstet Gynecol. 2013;56(1):193-201
11. Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs. 2012;41(2):180-190
12. Connaughton JF, Reeser D, Schut J, Finnegan LP. Perinatal addiction: outcome and management. Am J Obstet Gynecol. 1977;129(6):679-686
13. Jackson L, Ting A, McKay S, Galea P, Skeoch C. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F300-F304
14. Soepatmi S. Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy. Acta Paediatr Suppl. 1994;404(s404):36-39
15. Miles J, Sugumar K, Macrory F, Sims DG, D'Souza SW. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health Dev. 2007;33(2):206-212
16. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934-1940
17. Langley GJ, Moen R, Nolan KM, Nolan TW, Norman CL, Provost LP. The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. San Francisco, CA: Jossey-Bass; 2009
18. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141-158
19. nd ed. Nashville, TN: Neo Advances; 2010
20. Provost LP, Murray S. The Health Care Data Guide: Learning From Data for Improvement. San Francisco, CA: Jossey-Bass; 2011
21. Hall ES, Wexelblatt SL, Crowley M, et al OCHNAS Consortium. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014;134(2). Available at: www.pediatrics.org/cgi/content/full/134/2/e527
22. Behnke M, Smith VC; Committee on Substance Abuse; Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131(3). Available at: www.pediatrics.org/cgi/content/full/131/3/e1009